Journal article
Clinical Phenotypes of Cystic Fibrosis Carriers
Annual review of medicine, Vol.73(1), pp.563-574
01/27/2022
DOI: 10.1146/annurev-med-042120-020148
PMCID: PMC8884701
PMID: 35084992
Abstract
Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by mutations in
, the cystic fibrosis transmembrane conductance regulator gene. People with CF experience a wide variety of medical conditions that affect the pulmonary, endocrine, gastrointestinal, pancreatic, biliary, and reproductive systems. Traditionally, CF carriers, with one defective copy of
, were not thought to be at risk for CF-associated diseases. However, an emerging body of literature suggests that heterozygotes are at increased risk for many of the same conditions as homozygotes. For example, heterozygotes appear to be at increased risk for chronic pancreatitis, atypical mycobacterial infections, and bronchiectasis. In the United States alone, there are almost 10 million CF carriers. Universal newborn screening and prenatal genetic screening will identify more. Thus, there is a critical need to develop more precise estimates of health risks attributable to the CF carrier state across the lifespan.
Details
- Title: Subtitle
- Clinical Phenotypes of Cystic Fibrosis Carriers
- Creators
- Philip M Polgreen - University of IowaAlejandro P Comellas - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Annual review of medicine, Vol.73(1), pp.563-574
- DOI
- 10.1146/annurev-med-042120-020148
- PMID
- 35084992
- PMCID
- PMC8884701
- NLM abbreviation
- Annu Rev Med
- ISSN
- 0066-4219
- eISSN
- 1545-326X
- Grant note
- R01 AI143671 / NIAID NIH HHS UL1 TR002537 / NCATS NIH HHS
- Language
- English
- Date published
- 01/27/2022
- Academic Unit
- Pulmonary, Critical Care, and Occupational Medicine; Infectious Diseases; ICTS; Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984360055402771
Metrics
15 Record Views